共 5 条
- [1] Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Feigelson Heather Spencer,Cox David G,Cann Howard M,Wacholder Sholom,Kaaks Rudolf,Henderson Brian E,Albanes Demetrius,Altshuler David,Berglund Goran,Berrino Franco,Bingham Sheila,Buring Julie E,Burtt Noel P,Calle Eugenia E,Chanock Stephen J. Cancer Research . 2006
- [2] Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer. Kraft,Pharoah,Chanock,Albanes,Kolonel,Hayes,Altshuler,Andriole,Berg,Boeing,Burtt,Bueno-de-Mesquita,Calle,Cann,Canzian,Chen,Crawford,Dunning,Feigelson,Freedman,Gaziano,Giovannucci,Gonzalez,Haiman,Hallmans,Henderson,Hirschhorn,Hun. PLoS Genetics . 2005
- [3] Estrogen Pathway Polymorphisms and Mammographic Density. Isabelle Dumas,Caroline Diorio. Anticancer Research . 2011
- [4] HSD17B1 genetic variants and hormone receptor-defined breast cancer. Gaudet Mia M,Chanock Stephen,Dunning Alison,Driver Kristy,Brinton Louise A,Lissowska Jolanta,Peplonska Beata,Pharoah Paul,Garcia-Closas Montserrat. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology . 2008
- [5] Loss of Heterozygosity at 16q24.1?q24.2 Is Significantly Associated with Metastatic and Aggressive Behavior of Prostate Cancer. Jussi P. Elo,P?ivi H?rk?nen,Atte P. Kyll?nen,Olavi Lukkarinen,Matti Poutanen,Reijo Vihko,Pirkko Vih. Cancer Research . 1997